Trial Information
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Adjuvant Alectinib versus Adjuvant Platinum-Based Chemotherapy in Patients with Completely Resected Stage IB (Tumors = 4 CM) to Stage IIIA Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
